Format

Send to

Choose Destination
Front Oncol. 2018 Mar 21;8:70. doi: 10.3389/fonc.2018.00070. eCollection 2018.

Alterations of the Human Skin N- and O-Glycome in Basal Cell Carcinoma and Squamous Cell Carcinoma.

Author information

1
Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, Potsdam, Germany.
2
Institute of Chemistry and Biochemistry, Freie Universität Berlin, Berlin, Germany.
3
Department of Dermatology, Venerology and Allergology, Leipzig University Medical Center, Leipzig, Germany.
4
Department of Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg, Germany.
5
glyXera GmbH, Magdeburg, Germany.
6
Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan.
7
Institute for Glycomics, Griffith University, Southport, QLD, Australia.

Abstract

The glycome of one of the largest and most exposed human organs, the skin, as well as glycan changes associated with non-melanoma skin cancers have not been studied in detail to date. Skin cancers such as basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are among the most frequent types of cancers with rising incidence rates in the aging population. We investigated the healthy human skin N- and O-glycome and its changes associated with BCC and SCC. Matched patient samples were obtained from frozen biopsy and formalin-fixed paraffin-embedded tissue samples for glycomics analyses using two complementary glycomics approaches: porous graphitized carbon nano-liquid chromatography electro spray ionization tandem mass spectrometry and capillary gel electrophoresis with laser induced fluorescence detection. The human skin N-glycome is dominated by complex type N-glycans that exhibit almost similar levels of α2-3 and α2-6 sialylation. Fucose is attached exclusively to the N-glycan core. Core 1 and core 2 type O-glycans carried up to three sialic acid residues. An increase of oligomannose type N-glycans and core 2 type O-glycans was observed in BCC and SCC, while α2-3 sialylation levels were decreased in SCC but not in BCC. Furthermore, glycopeptide analyses provided insights into the glycoprotein candidates possibly associated with the observed N-glycan changes, with glycoproteins associated with binding events being the most frequently identified class.

KEYWORDS:

basal cell carcinoma; glycomics; glycosylation; non melanoma skin cancer; oligomannose; skin glycans; squamous cell carcinoma

Supplemental Content

Full text links

Icon for Frontiers Media SA Icon for PubMed Central
Loading ...
Support Center